Evidence map›Paper›PMID 42308524›Full record

ArticleBioinformatics (Oxford, England)2026

needLR: long-read structural variant annotation with population-scale frequency estimation.

Jonas A Gustafson, Jiadong Lin, Miranda P G Zalusky, Evan E Eichler, Danny E Miller

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Jonas A GustafsonDepartment of Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, United States.ORCID 0000-0002-5748-905X
Jiadong LinDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, United States.
Miranda P G ZaluskyDepartment of Pediatrics, University of Washington, Seattle, WA 98195, United States.
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, United States.ORCID 0000-0002-8246-4014
Danny E MillerDepartment of Pediatrics, University of Washington, Seattle, WA 98195, United States.ORCID 0000-0001-6096-8601

Funding

Sequence-resolved structural variation of human genomesR01HG010169 · NHGRI · UNIVERSITY OF WASHINGTON · PI Evan Eichler · 2018 to 2026
$4.5M
Long-read DNA and RNA sequencing to identify disease-causing genetic variation and streamline testingDP5OD033357 · OD · UNIVERSITY OF WASHINGTON · PI MILLER, DANNY ERWIN · 2022 to 2025
$1.9M
NHGRI NIH HHS R01 HG010169NIH HHS DP5 OD033357NIH HHS DP5OD033357
6 · The paper itself

Abstract

summaryWe present needLR, a structural variant (SV) annotation tool that can be used for filtering and prioritization of candidate pathogenic SVs from long-read sequencing data using population allele frequencies, annotations for genomic context, and gene-phenotype associations. When using population data from 500 presumably healthy individuals to evaluate nine test cases with known pathogenic SVs, needLR assigned allele frequencies to over 97.5% of all detected SVs and reduced the average number of novel genic SVs to 121 per case while retaining all known pathogenic variants. AVAILABILITY AND IMPLEMENTATION: needLR is implemented in bash with dependencies including Truvari v4.2.2, BEDTools v2.31.1, and BCFtools v1.19. Source code, documentation, and pre-computed population allele frequency data are freely available at https://github.com/jgust1/needLR under an MIT license and archived on Zenodo at https://zenodo.org/records/19463479.

Indexed as

Gene FrequencyGenomic Structural VariationMolecular Sequence AnnotationSoftwareGenomicsHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNA

Identifiers

PMID42308524
PMCPMC13332437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.